rs10782529
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs10782529(C;C) |
Make rs10782529(C;T) |
Make rs10782529(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 1 |
Position | 84802560 |
is a | snp |
is | mentioned by |
dbSNP | rs10782529 |
dbSNP (classic) | rs10782529 |
ClinGen | rs10782529 |
ebi | rs10782529 |
HLI | rs10782529 |
Exac | rs10782529 |
Gnomad | rs10782529 |
Varsome | rs10782529 |
LitVar | rs10782529 |
Map | rs10782529 |
PheGenI | rs10782529 |
Biobank | rs10782529 |
1000 genomes | rs10782529 |
hgdp | rs10782529 |
ensembl | rs10782529 |
geneview | rs10782529 |
scholar | rs10782529 |
rs10782529 | |
pharmgkb | rs10782529 |
gwascentral | rs10782529 |
openSNP | rs10782529 |
23andMe | rs10782529 |
SNPshot | rs10782529 |
SNPdbe | rs10782529 |
MSV3d | rs10782529 |
GWAS Ctlg | rs10782529 |
GMAF | 0.348 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23118302] |
Trait | Lipoprotein-associated phospholipase A2 activity change in response to statin therapy |
Title | Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy. |
Risk Allele | C |
P-val | 4E-6 |
Odds Ratio | 1.70 [1.11-2.29] percent increase |